Dr. Brian Hawkins, Chief Technology Officer, Pluristyx, talks to RegMedNet about how protocols surrounding ATMP cryopreservation have changed over recent years. Dr. Hawkins focuses on the challenges of cryopreservation and discusses how programs readily adapt to the scale-up, tech transfer and late-stage clinical trials that occur during commercialization
Pluristyx Featured in Labroots Webinar
September 4, 2022
Dr. Ben Fryer, Co-Founder and CEO of Pluristyx, presented to webinar participants the “how and why” of integrating high quality ancillary raw materials into cell therapy product development and the manufacturing workflow, beginning with the starting cell source and MCB